Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study.

Yuko Miura,Yosuke Tsuji,Toshiyuki Yoshio,Waku Hatta,Yohei Yabuuchi,Shu Hoteya,Daisuke Kikuchi,Shigetsugu Tsuji,Yasuaki Nagami,Takuto Hikichi,Masakuni Kobayashi,Yoshinori Morita,Tetsuya Sumiyoshi,Mikitaka Iguchi,Hideomi Tomida,Takuya Inoue,Tatsuya Mikami,Kenkei Hasatani,Jun Nishikawa,Tomoaki Matsumura,Hiroko Nebiki,Dai Nakamatsu,Ken Ohnita,Haruhisa Suzuki,Hiroya Ueyama,Yoshito Hayashi,Mitsushige Sugimoto,Shinjiro Yamaguchi,Tomoki Michida,Tomoyuki Yada,Yoshiro Asahina,Toshiaki Narasaka,Shiko Kuribayashi,Shu Kiyotoki,Katsuhiro Mabe,Atsushi Masamune,Mitsuhiro Fujishiro
DOI: https://doi.org/10.1016/j.gie.2022.12.025
IF: 10.396
2023-01-01
Gastrointestinal Endoscopy
Abstract:Replacement of thienopyridine with aspirin or cilostazol may be acceptable for minimizing both the risk of post-ESD bleeding and thromboembolism in patients with EGC. In patients on cilostazol monotherapy undergoing ESD, continuation of therapy may be acceptable.
What problem does this paper attempt to address?